These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 16564596

  • 1. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes.
    Chiu SJ, Liu S, Perrotti D, Marcucci G, Lee RJ.
    J Control Release; 2006 May 15; 112(2):199-207. PubMed ID: 16564596
    [Abstract] [Full Text] [Related]

  • 2. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ, Marcucci G, Lee RJ.
    Anticancer Res; 2006 May 15; 26(2A):1049-56. PubMed ID: 16619505
    [Abstract] [Full Text] [Related]

  • 3. Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2.
    Yang X, Koh CG, Liu S, Pan X, Santhanam R, Yu B, Peng Y, Pang J, Golan S, Talmon Y, Jin Y, Muthusamy N, Byrd JC, Chan KK, Lee LJ, Marcucci G, Lee RJ.
    Mol Pharm; 2009 May 15; 6(1):221-30. PubMed ID: 19183107
    [Abstract] [Full Text] [Related]

  • 4. Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide g3139 in a murine k562 xenograft model.
    Zhang X, Koh CG, Yu B, Liu S, Piao L, Marcucci G, Lee RJ, Lee LJ.
    Pharm Res; 2009 Jun 15; 26(6):1516-24. PubMed ID: 19291371
    [Abstract] [Full Text] [Related]

  • 5. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee RJ.
    J Pharm Pharm Sci; 2007 Jun 15; 10(3):350-7. PubMed ID: 17727798
    [Abstract] [Full Text] [Related]

  • 6. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X, Ding L, Xu Y, Wang Y, Ping Q.
    Int J Pharm; 2009 May 21; 373(1-2):116-23. PubMed ID: 19429296
    [Abstract] [Full Text] [Related]

  • 7. Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.
    Lopes de Menezes DE, Hudon N, McIntosh N, Mayer LD.
    Clin Cancer Res; 2000 Jul 21; 6(7):2891-902. PubMed ID: 10914739
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficient delivery of antisense oligodeoxyribonucleotide g3139 by human serum albumin-coated liposomes.
    Weecharangsan W, Yu B, Zheng Y, Liu S, Pang JX, Lee LJ, Marcucci G, Lee RJ.
    Mol Pharm; 2009 Jul 21; 6(6):1848-55. PubMed ID: 19725564
    [Abstract] [Full Text] [Related]

  • 11. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY, Liu C, Hong MH, Zhu SJ, Pei YY.
    Bioconjug Chem; 2007 Jul 21; 18(1):41-9. PubMed ID: 17226956
    [Abstract] [Full Text] [Related]

  • 12. Coaxial electrohydrodynamic spraying: a novel one-step technique to prepare oligodeoxynucleotide encapsulated lipoplex nanoparticles.
    Wu Y, Yu B, Jackson A, Zha W, Lee LJ, Wyslouzil BE.
    Mol Pharm; 2009 Jul 21; 6(5):1371-9. PubMed ID: 19499922
    [Abstract] [Full Text] [Related]

  • 13. A transferrin receptor-targeted liposomal formulation for docetaxel.
    Zhai G, Wu J, Yu B, Guo C, Yang X, Lee RJ.
    J Nanosci Nanotechnol; 2010 Aug 21; 10(8):5129-36. PubMed ID: 21125861
    [Abstract] [Full Text] [Related]

  • 14. G3139 induces cell death by caspase-dependent and -independent apoptosis on human melanoma cell lines.
    Nakamura S, Inui M, Kamei T, Nakase M, Okumura K, Tagawa T.
    Oncol Rep; 2006 Jun 21; 15(6):1563-8. PubMed ID: 16685396
    [Abstract] [Full Text] [Related]

  • 15. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
    Kobayashi T, Ishida T, Okada Y, Ise S, Harashima H, Kiwada H.
    Int J Pharm; 2007 Feb 01; 329(1-2):94-102. PubMed ID: 16997518
    [Abstract] [Full Text] [Related]

  • 16. In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.
    Anabousi S, Bakowsky U, Schneider M, Huwer H, Lehr CM, Ehrhardt C.
    Eur J Pharm Sci; 2006 Dec 01; 29(5):367-74. PubMed ID: 16952451
    [Abstract] [Full Text] [Related]

  • 17. Bcl-2 protein in 518A2 melanoma cells in vivo and in vitro.
    Benimetskaya L, Ayyanar K, Kornblum N, Castanotto D, Rossi J, Wu S, Lai J, Brown BD, Popova N, Miller P, McMicken H, Chen Y, Stein CA.
    Clin Cancer Res; 2006 Aug 15; 12(16):4940-8. PubMed ID: 16914583
    [Abstract] [Full Text] [Related]

  • 18. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
    Tang J, Zhang L, Liu Y, Zhang Q, Qin Y, Yin Y, Yuan W, Yang Y, Xie Y, Zhang Z, He Q.
    Int J Pharm; 2013 Sep 15; 454(1):31-40. PubMed ID: 23850793
    [Abstract] [Full Text] [Related]

  • 19. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo.
    Hatakeyama H, Akita H, Maruyama K, Suhara T, Harashima H.
    Int J Pharm; 2004 Aug 20; 281(1-2):25-33. PubMed ID: 15288340
    [Abstract] [Full Text] [Related]

  • 20. Targeting liposomes with protein drugs to the blood-brain barrier in vitro.
    Visser CC, Stevanović S, Voorwinden LH, van Bloois L, Gaillard PJ, Danhof M, Crommelin DJ, de Boer AG.
    Eur J Pharm Sci; 2005 Jun 20; 25(2-3):299-305. PubMed ID: 15911226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.